AKR7A2 Citations (3)
Originally described in: SGC+yearunpublished
Articles Citing AKR7A2
| Articles |
|---|
| Inhibition of human anthracycline reductases by emodin - A possible remedy for anthracycline resistance. Hintzpeter J, Seliger JM, Hofman J, Martin HJ, Wsol V, Maser E. Toxicol Appl Pharmacol. 2016 Jan 7;293:21-29. doi: 10.1016/j.taap.2016.01.003. PubMed |
| Indirect DNA Sequence Recognition and Its Impact on Nuclease Cleavage Activity. Lambert AR, Hallinan JP, Shen BW, Chik JK, Bolduc JM, Kulshina N, Robins LI, Kaiser BK, Jarjour J, Havens K, Scharenberg AM, Stoddard BL. Structure. 2016 Jun 7;24(6):862-73. doi: 10.1016/j.str.2016.03.024. Epub 2016 Apr 28. PubMed |
| Roscovitine and purvalanol A effectively reverse anthracycline resistance mediated by the activity of aldo-keto reductase 1C3 (AKR1C3): A promising therapeutic target for cancer treatment. Novotna E, Bukum N, Hofman J, Flaxova M, Kouklikova E, Louvarova D, Wsol V. Biochem Pharmacol. 2018 Oct;156:22-31. doi: 10.1016/j.bcp.2018.08.001. Epub 2018 Aug 3. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.